Skip to main content
OpenTrials

Clinical trial condition

Thromboembolism

Explore clinical trials studying Thromboembolism. Study availability and eligibility vary by location and protocol.

113 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Thromboembolism trial results

Completed

Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism

NCT00291330

Conditions
Cardiovascular Diseases, Embolism and Thrombosis, Thromboembolism, +1 more
Locations
  • 1160.53.01035 Boehringer Ingelheim Investigational Site Mobile, Alabama, United States
  • 1160.53.01056 Boehringer Ingelheim Investigational Site Hartford, Connecticut, United States
  • 1160.53.01044 Boehringer Ingelheim Investigational Site Clearwater, Florida, United States
  • 1160.53.01033 Boehringer Ingelheim Investigational Site Sarasota, Florida, United States
View all 250 locations
View Trial Details
Completed

Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery

NCT00168818

Conditions
Arthroplasty, Replacement, Hip, Cardiovascular Diseases, Embolism and Thrombosis, +2 more
Locations
  • 1160.48.06108 Canberra Hospital Garren, Australian Capital Territory, Australia
  • 1160.48.06106 St George Public Hospital Kogarah, New South Wales, Australia
  • 1160.48.06110 Suite 13 level 4 Lismore, New South Wales, Australia
  • 1160.48.06105 Flinders Medical Centre Bedford Park, South Australia, Australia
View all 116 locations
View Trial Details
Completed

RE-MODEL Dabigatran Etexilate 150mg or 220mg Once Daily (o.d.) Versus (v.s.) Enoxaparin 40mg o.d. for Prevention of Thrombosis After Knee Surgery

NCT00168805

Conditions
Arthroplasty, Replacement, Knee, Cardiovascular Diseases, Embolism and Thrombosis, +2 more
Locations
  • 1160.25.06108 Boehringer Ingelheim Investigational Site Garren, Australian Capital Territory, Australia
  • 1160.25.06106 Boehringer Ingelheim Investigational Site Kogarah, New South Wales, Australia
  • 1160.25.06110 Boehringer Ingelheim Investigational Site Lismore, New South Wales, Australia
  • 1160.25.06105 Boehringer Ingelheim Investigational Site Bedford Park, South Australia, Australia
View all 105 locations
View Trial Details
Completed

Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)

NCT00680186

Conditions
Cardiovascular Diseases, Embolism and Thrombosis, Thromboembolism, +1 more
Locations
  • 1160.46.01073 Boehringer Ingelheim Investigational Site Little Rock, Arkansas, United States
  • 1160.46.01044 Boehringer Ingelheim Investigational Site Clearwater, Florida, United States
  • 1160.46.01068 Boehringer Ingelheim Investigational Site Normal, Illinois, United States
  • 1160.46.01071 Boehringer Ingelheim Investigational Site Shreveport, Louisiana, United States
View all 220 locations
View Trial Details
Completed

Secondary Prevention of Venous Thrombo Embolism (VTE).

NCT00329238

Conditions
Cardiovascular Diseases, Embolism and Thrombosis, Thromboembolism, +1 more
Locations
  • 1160.47.01035 Boehringer Ingelheim Investigational Site Mobile, Alabama, United States
  • 1160.47.01056 Boehringer Ingelheim Investigational Site Hartford, Connecticut, United States
  • 1160.47.01044 Boehringer Ingelheim Investigational Site Clearwater, Florida, United States
  • 1160.47.01019 Boehringer Ingelheim Investigational Site Augusta, Georgia, United States
View all 275 locations
View Trial Details
Completed

Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement

NCT00152971

Conditions
Arthroplasty, Replacement, Knee, Cardiovascular Diseases, Embolism and Thrombosis, +2 more
Locations
  • 1160.24.01074 Capstone Clinical Trials, Inc. Birmingham, Alabama, United States
  • 1160.24.01079 West AL Research, Inc Northport, Alabama, United States
  • 1160.24.01047 Tucson Orhtopaedic Institute Tucson, Arizona, United States
  • 1160.24.01025 Martin, Bowen, Hefley Knee and Sports Little Rock, Arkansas, United States
View all 94 locations
View Trial Details
Completed

Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

NCT00462852

Conditions
Cardiovascular Diseases, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations
  • Princess Royal Hospital at Hull and East Yorkshire NHS Trust Hull, England, United Kingdom
  • Royal Lancaster Infirmary Lancaster, England, United Kingdom
  • Saint Bartholomew's Hospital London, England, United Kingdom
  • St. George's Hospital London, England, United Kingdom
View Trial Details
Completed

Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters

NCT00024297

Conditions
Cardiovascular Diseases, Embolism and Thrombosis, Thromboembolism, +1 more
Locations
  • Queen Elizabeth Hospital at University of Birmingham Birmingham, England, United Kingdom
  • City Hospital - Birmingham Birmingham, England, United Kingdom
  • Birmingham Heartlands and Solihull NHS Trust -Teaching Birmingham, England, United Kingdom
  • Bristol Haematology and Oncology Centre Bristol, England, United Kingdom
View all 38 locations
View Trial Details

Related conditions